Curated News
By: NewsRamp Editorial Staff
July 17, 2026
Garlic Variety Breakthrough: Antiviral Studies Support New Products at Gilroy Festival
TLDR
- SupaG Health's proprietary garlic cultivars with proven antiviral activity offer a competitive edge in the nutraceutical market.
- Peer-reviewed lab studies identified specific garlic cultivars that block viral entry, enabling targeted supplement formulations.
- Cultivar-specific garlic supplements may offer natural support against respiratory viruses, improving global health outcomes.
- Over 300 garlic varieties were analyzed to discover that only a few have potent antiviral properties against COVID and flu.
Impact - Why it Matters
This research matters because it challenges the notion that all garlic provides the same health benefits, potentially transforming the nutraceutical industry by offering cultivar-specific, evidence-based formulations. For consumers, it means future garlic supplements could be more effective against viruses like COVID and influenza, backed by science rather than tradition. For the garlic industry, it opens new commercial opportunities in premium health products, moving from generic commodities to targeted functional foods. However, readers should note that the studies are in vitro, not clinical, and products are not intended to treat or prevent disease.
Summary
Nick Diamantopoulos, founder of SupaG Health Pty Ltd, is set to unveil new garlic products at the renowned Gilroy Garlic Festival this July, backed by peer-reviewed studies showing specific garlic varieties possess significant antiviral properties. The research, published in the Journal of Functional Foods (2024) and JSFA Reports (2026), demonstrated in laboratory settings that certain garlic extracts inhibited SARS-CoV-2 and Influenza A viruses by impeding viral entry into host cells. Crucially, the same cultivars showed activity across both viruses, suggesting the properties are linked to the garlic variety itself rather than growing location. Diamantopoulos emphasizes that not all garlic is equal for health benefits, and this research opens the door to entirely new categories of garlic health products.
Drawing on over 30 years of collection and breeding involving more than 300 garlic varieties from around the world, SupaG Health aims to move beyond generic garlic commodities toward health-specific cultivars with targeted functional properties, proprietary formulations, and traceable genetics. At the Gilroy Garlic Festival, the company will present a premium garlic supplement supported by peer-reviewed research and is actively pursuing distribution partnerships, nutraceutical and pharmaceutical collaborations, and retail expansion. The festival, the nation's premier summer food event, provides an ideal platform for Diamantopoulos to discuss commercial development plans and opportunities for strategic partnerships.
The research underscores that biological activity depends on garlic cultivar, extraction methods, and processing controls, creating opportunities for intellectual property around identified cultivars and proprietary formulations in the nutraceutical, functional food, and pharma sectors. Diamantopoulos believes these discoveries represent one of the most historically significant scientific developments in the garlic industry, establishing a scientific foundation for a new premium category. Media contact: Nick Diamantopoulos, available at the Gilroy Garlic Festival on July 24-26, via email at Nick@australiangarlic.com.au or cell: +61 417 312 760. Note: The studies were conducted in laboratory settings and do not constitute clinical evidence in humans; these statements have not been evaluated by the FDA.
Source Statement
This curated news summary relied on content disributed by 24-7 Press Release. Read the original source here, Garlic Variety Breakthrough: Antiviral Studies Support New Products at Gilroy Festival
